Pavilion Publishing and Media Ltd
Blue Sky Offices Shoreham, 25 Cecil Pashley Way, Shoreham-by-Sea, West Sussex, BN43 5FF, UNITED KINGDOM
Spotlight: management of primary biliary cholangitis
Primary biliary cholangitis (PBC) is a rare, auto-immune cholestatic liver disease. This article discusses the management of PBC and emerging potential treatment options.
Liver disease is becoming more prevalent in the UK, and it is the only major chronic disease where death rates are rising.1
Over the past few decades, new medications, technologies, and other innovations have been developed to try and tackle this growing need, but innovations in rare liver disease are still lacking.
For example, there have been no new effective treatments for primary biliary cholangitis (PBC) – a rare, auto-immune cholestatic liver disease – for more than a decade.
This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.